ArticleJournal of medical physics
Deep Learning-based Volumetric Modulated Arc Therapy Dose Prediction with Uncertainty Quantification for Left- and Right-sided Breast Cancer: A Single-institution Feasibility Study.
Article in Journal of medical physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Volumetric-modulated arc therapy (VMAT) enables precise tumor targeting while minimizing dose to organs at risk but requires time-consuming planning with quality variability. Most deep learning (DL) dose prediction studies focus on left-sided breast cancer, with limited exploration of right-sided cases or integrated uncertainty quantification. This study investigates the feasibility of a DL model for VMAT dose prediction in both left-and right-sided breast cancer, incorporating Monte Carlo dropout (MCD)-based uncertainty quantification within a single-institution dataset. Methods: A total of 68 clinically accepted breast cancer VMAT treatment plans (41 left-sided, 27 right-sided) were collected. A three-dimensional U-Net architecture was implemented. Two models with dropout rates of 0.25 (M0.25) and 0.50 (M0.50) were developed. MCD was applied for uncertainty quantification. Performance was evaluated using mean absolute error (MAE), gamma passing rate (GPR), and isodose Dice similarity coefficients. Results: The overall body MAE was 1.7 ± 0.11 Gy (M0.25) and 1.93 ± 0.11 Gy (M0.50). For the planning target volume (PTV) of 42.56 Gy, MAE was 0.93 ± 0.17 Gy (M0.25) and 0.88 ± 0.15 Gy (M0.50). The heart showed the lowest errors (M0.25: 0.87 ± 0.34 Gy; M0.50: 1.06 ± 0.38 Gy), while contralateral lung exhibited higher uncertainties. GPR at 3%/3 mm reached 85.5% for both models, with no significant difference between left- and right-sided cases. Uncertainty maps correlated with prediction errors (Pearson correlation =0.59) and identified regions with atypical anatomies. Conclusions: The proposed model supports the feasibility of VMAT dose prediction for both left-and right-sided breast cancer, while the uncertainty maps provide additional confidence information to assist clinical interpretation and decision-making. Uncertainty maps correlated with prediction error and flagged atypical cases. External validation with a larger, multi-institutional dataset is required before clinical implementation can be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.